SCHEMBL29355686

SCHEMBL29355686

CN(CCN(C)c1ccc(N)cc1C[S+](C)[O-])C(=O)OC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.35
PDK2 Q15119 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19742593 0.85 HCAR3 (0.34)
SCHEMBL19742538 0.83 CKS1B (0.42)
SCHEMBL19742630 0.80 PRKCI (0.32)
SCHEMBL19742584 0.79 MAPK1 (0.31)
SCHEMBL19754010 0.76 PPIA (0.32)
SCHEMBL19753974 0.76 HCAR3 (0.37)
SCHEMBL19742573 0.75 LMNA (0.33)
SCHEMBL19742596 0.75 PHLPP2 (0.34)
SCHEMBL29356449 0.74 PPIB (0.32)
SCHEMBL18186254 0.74 HTR2C (0.38) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3474855-B1 CK2 INHIBITORS, COMPOSITIONS AND METHODS THEREOF POLARIS PHARMACEUTICALS INC (US) 2022-01-26 EP disclosed